EMERGENT BIOSOLUTIONS INC. COMMON STOCK
9.4800
22-November-24 16:29:59
15 minutes delayed
Stocks
+0.0800
+0.85%
Today's range
9.3700 - 9.6700
ISIN
N/A
Source
NYSE
-
08 Apr 2022 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Provides Corporate Governance Update
23 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
14 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
11 Mar 2022 06:34:09 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
24 Feb 2022 16:05:03 By Nasdaq GlobeNewswire
-
07 Feb 2022 06:30:00 By Nasdaq GlobeNewswire
-
Founder and Executive Chairman of Emergent BioSolutions Announces Retirement
14 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces 2022 Financial Guidance, Provides Preliminary 2021 Results
09 Jan 2022 14:00:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
03 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
16 Dec 2021 07:30:29 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Announces Stock Repurchase Program
11 Nov 2021 16:05:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results For Third Quarter 2021
04 Nov 2021 16:05:02 By Nasdaq GlobeNewswire
-
18 Oct 2021 06:30:00 By Nasdaq GlobeNewswire
-
15 Oct 2021 06:30:00 By Nasdaq GlobeNewswire
-
14 Sep 2021 08:00:02 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Participate in Investor Conferences
23 Aug 2021 16:05:00 By Nasdaq GlobeNewswire
-
Emergent BioSolutions Reports Financial Results For Second Quarter 2021
29 Jul 2021 16:05:01 By Nasdaq GlobeNewswire
-
Emergent BioSolutions to Resume Manufacturing Covid-19 Vaccine at Bayview Facility
29 Jul 2021 07:24:59 By Nasdaq GlobeNewswire
-
Reverse the Silence Campaign Casts a National Spotlight on Overdose Risks Associated with Opioid Use
26 Jul 2021 09:01:00 By Nasdaq GlobeNewswire